With more than 26% of adults classified as obese and an additional 38% considered to be overweight, obesity remains a significant public health challenge in the UK.
This epidemic not only impacts individual health but also places a substantial burden on the NHS and economic performance, reports Ramesh Jassal (pictured), Partner at the Heligan Group.
Recent advancements in weight loss interventions, including pharmacological treatments and surgical procedures, alongside remedies offered by online and in-person pharmacies, are transforming the healthcare landscape and presenting new merger and acquisition (M&A) opportunities. Recent sector developments include the following.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.